Molecular Basis of HLA-C Recognition by p58 Natural Killer Cell Inhibitory Receptors

Journal of Immunology

Volumn 159, Issue 8, 1997, Pages 3875-3882

  Kim, Jongsun ^a   Chwae, Yong Joon ^a   Kim, Mi Yeon ^a   Choi, In Hong ^a   Park, Jeon Han ^a   Kim, Se Jong ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; COMPLEMENTARY DNA; HLA C ANTIGEN; IMMUNOGLOBULIN; IMMUNOGLOBULIN RECEPTOR; KILLER ACTIVATORY RECEPTOR; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR; PEPTIDE;

AMINO ACID SEQUENCE; ARTICLE; BIOSYNTHESIS; BLOOD DONOR; CHEMISTRY; GENETICS; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; METABOLISM; MOLECULAR CLONING; MOLECULAR GENETICS; NATURAL KILLER CELL; PHYSIOLOGY; PROTEIN BINDING; PROTEIN FOLDING; PROTEIN TERTIARY STRUCTURE; SOLUBILITY;

AMINO ACID SEQUENCE; ANTIGENS; BLOOD DONORS; CLONING, MOLECULAR; DNA, COMPLEMENTARY; HLA-C ANTIGENS; HUMANS; IMMUNOGLOBULINS; KILLER CELLS, NATURAL; MOLECULAR SEQUENCE DATA; PEPTIDES; PROTEIN BINDING; PROTEIN FOLDING; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, IMMUNOLOGIC; SOLUBILITY;

EID: 0031572590     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Trinchieri, G. 1989. Biology of natural killer cells. Adv. Immunol. 47:187.
2. Moretta, A., C. Bottino, M. Vitale, D. Pende, R. Biassoni, M. C. Mingari, and L. Moretta. 1996. Receptors for HLA class I molecules in human natural killer cells. Adv. Rev. Immunol. 14:619.
3. Raulet, D. H., and W. Held. 1995. Natural killer cell receptors: the offs and ons of NK cell recognition. Cell 82:697.
4. Gumperz, J. E., and P. Parham. 1995. The enigma of the natural killer cell. Nature 378:245.
5. Bezouska, K., C-T. Yuen, J. O'Brien, R. A. Childs, W. Chai, A. M. Lawson, K. Drbal, A. Fiserova, M. Pospisil, and T. Feizi. 1994. Oligosacharide ligands for NKR-P1 protein activate NK cells and cytotoxicity. Nature 372:150.
6. Karlhofer, F. M., and W. M. Yokoyama. 1991. Stimulation of murine natural killer (NK) cells by a monoclonal antibody specific for the NK1.1 antigen: IL-2-activated NK cells possess additional specific stimulation pathways. J. Immunol. 146:3662.
7. Moretta, A., A. Poggi, D. Pende, G. Tripodi, A. M. Orengo, N. Pella, R. Augugliaro, C. Bottino, E. Ciccone, and L. Moretta. 1991. CD69-mediated pathway of lymphocyte activation: anti-CD69 mAbs trigger the cytolytic activity of different lymphoid effector cells with the exception of cytolytic T lymphocytes expressing TCR αβ. J. Exp. Med. 174:1393.
8. Lanier, L. L., J. J. Ruitenberg, and J. H. Philips. 1988. Functional and biochemical analysis of CD16 antigen on natural killer cells and granulocyles. J. Immunol. 141:3478.
9. Seaman, W. E., E. Erickson, R. Dobrow, and J. B. Imboden. 1987. Inositol triphosphate is generated by a rat natural killer cell tumor in response to target cells or to cross-linked monoclonal antibody OX-34: possible signaling role for the OX-34 determinant during activation by target cells. Proc. Natl. Acad. Sci. USA 84:4239.
10. Chambers, W. H., N. L. Vujanovic, A. B. DeLeo, M. W. Olszowy, R. B. Herberman, and J. C. Hiserodt. 1989. Monoclonal antibody to a triggering structure expressed on rat natural killer cells and adherent lymphokine-activated killer cells. J. Exp. Med. 169:1373.
11. Storkus, W. J., J. Alexander, J. A. Payne, J. R. Dawson, and P. Cresswell. 1989. Reversal of natural killing susceptibility in target cells expressing transfected class I HLA genes. Proc. Natl. Acad. Sci. USA 86:2361.
12. Shimizu, Y., and R. DeMars. 1989. Demonstration by class I gene transfer that reduced susceptibility of human cells to natural killer cell-mediated lysis is inversely correlated with HLA class I antigen expression. Eur. J. Immunol. 19:447.
13. Litwin, V., J. Gumperz, P. Parham, J. H. Phillips, and L. L. Lanier. 1993. Specificity of HLA class I antigen recognition by human NK clones: evidence for clonal heterogeneity, protection by self and non-self alleles, and influence of the target cell. J. Exp. Med. 178:1321.
14. Kärre, K., H. G. Ljunggren, G. Piontek, and R. Kiessling. 1986. Selective rejection of II-2-deficient lymphoma variants suggests alternative immune defense strategy. Nature 319:675.
15. Chan, P-Y., and F. Takei. 1989. Molecular cloning and characterization of a novel murine T cell surface antigen, YE1/48. J. Immunol. 142:1727.
16. Yokoyama, W. H., L. B. Jacobs, O. Kanagawa, E. M. Shevach, and D. I. Cohen. 1989. A murine T lymphocyte antigen belongs to a supergene family of type II integral membrane proteins. J. Immunol. 143:1379.
17. Wong, S., J. D. Freeman, C. Kelleher, D. Mager, and F. Takei. 1991. Ly-49 multigene family: new members of a superfamily of type II membrane proteins with lectin-like domains. J. Immunol. 147:1417.
18. Brennan, J., D. Mager, W. Jefferies, and F. Takei. 1994. Expression of different members of the Ly-49 gene family defines distinct natural killer cell subsets and cell adhesion properties. J. Exp. Med. 180:2287.
19. Smith, H. R. C., F. M. Karlhofer, and W. M. Yokoyama. 1994. Ly-49 multigene family expressed by IL-2 activated NK cells. J. Immunol. 153:1068.
20. + IL-2-activated natural killer cells. Nature 358:66.
21. d, has a functional carbohydrate recognition domain. Immunity 1:785.
22. Moretta, A., M. Vitale, C. Botino, A. M. Orengo, L. Morelli, R. Augugliaro, M. Barbaresi, E. Ciccone, and L. Moretta. 1993. P58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells: anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities. J. Exp. Med. 178:597.
23. Vitale, M., S. Sivoris, D. Pende, A. Moretta, and L. Moretta. 1995. The coexpression of two functionally independent p48 inhibitory receptors in human NK clones results in the inability to kill all normal allogenic target cells. Proc. Natl. Acad. Sci. USA 92:3536.
24. Wagtmann, N., R. Biassoni, C. Cantoni, S. Verdiani, M. S. Malnati, M. Vitale, C. Bottino, L. Moretta, A. Moretta, and E. O. Long. 1995. Molecular clones of the p58 NK cell receptor reveal Immunoglobulin-relaled molecules with diversity in both the extra- and intracellular domains. Immunity 2:439.
25. Colonna, M., and J. Samaridis. 1995. Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells. Science 268:405.
26. Wagtmann, N., S. Rajagopalan, C. C. Winter, M. Peruzzi, and E. O. Long. 1995. Killer cell inhibitory receptors specific for HLA-C and HLA-B identified by direct binding and by functional transfer. Immunity 3:801.
27. Litwin, V., J. Gumperz, P. Parham, J. H. Phillips, and L. L. Lanier. 1994. NKB1: a natural killer cell receptor involved in the recognition of polymorphic HLA-B molecules. J. Exp. Med. 180:537.
28. Dohring, C., D. Scheidegger, J. Samaridis, M. Cella, and M. Colonna. 1996. A human killer inhibitory receptor specific for HLA-A. J. Immunol. 156:3098.
29. Pende, D., R. Biassoni, C. Cantoni, S. Verdiani, M. Falco, C. Di Donato, L. Accame, C. Bottino, A. Moretta, and L. Moretta. 1996. The natural killer cell receptor specific for HLA-A allotypes: a novel member of the p58/p70 family of inhibitory receptors which is characterized by three Ig-like domains and is expressed as a 140-kd disulfide-linked dimer. J. Exp. Med. 184:505.
30. Gumperz, J. E., V. Litwin, J. H. Phillips, L. L. Lanier, and P. Parham. 1995. The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor. J. Exp. Med. 181:1133.
31. Moretta, A., S. Sivori, M. Vitale, D. Pende, L. Morelli, R. Augugliaro, C. Bottino, and L. Moretta. 1995. Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells. J. Exp. Med. 182:875.
32. Biassoni, R., C. Cantoni, M. Falco, S. Verdani, C. Bottino, M. Vitale, R. Conte, A. Poggi, A. Moretta, and L. Moretta. 1996. The human leukocyte antigen (HLA)-C specific "activatory" or "inhibitory" natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions. J. Exp. Med. 183:645.
33. Ciccone, E., D Pende, O. Vitale, A. Than, C. Di Donato, A. M. Orengo, R. Biassoni, S. Verdiani, A. Amoroso, A. Moretta, and L. Moretta. 1992. Involvement of HLA class I alleles in natural killer (NK) cell-specific functions: expression of HLA-Cw3 confers selective protection from lysis by alloreactive NK clones displaying a deficient specificity (specificity 2). J. Exp. Med. 176:963.
34. Colonna, M., G. Borsellino, M. Falco, G. B. Ferrara, and J. L. Strominger. 1993. HLA-C is the inhibitory ligand that determines dominant resistance to lysis by NK1- and NK2-specific natural killer cells. Proc. Natl. Acad. Sci. USA 90:12000.
35. Moretta, A., M. Vitale, S. Sivori, C. Bottino, L. Morelli, K. Augugliaro, M. Barbaresi, D. Pende, E. Ciccone, M. Lopez-Botet, and L. Moretta. 1994. Human natural killer cell receptors for HLA class I molecules: evidence that the Kp43 (CD 94) molecule functions as receptor for HLA-B alleles. J. Exp. Med. 180:545.
36. Ciccone, E., D. Pende, M. Vitale, L. Nanni, C. Di Donato, C. Bottino, L. Morelli, O. Vitale, A. Amoroso, A. Moretta, and L. Moretta. 1994. Self class I molecules protect normal cells from lysis mediated by autologous natural killer cells. Eur. J. Immunol. 24:1003.
37. Fan., Q. R., D. N. Garboczi, C. C. Winter, N. Wagtmann, E. O. Long, and D. C. Wiley. 1996. Direct binding of a soluble natural killer cell inhibitory receptor to a soluble human leukocyte antigen-Cw4 class I major histocompatibility complex molecule. Proc. Natl. Acad. Sci. USA 93:7178.
38. Garboczi, D. N., D. T. Hung, and D. C. Wiley. 1992. HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in E. coli and complexed with single antigenic peptides. Proc. Natl. Acad. Sci. USA 89:3429.
39. Falk, K., O. Rotzschke, B. Grahovac, D. Schendel, S. Stevanovic, V. Gnau, G. Jung, J. L. Strominger, and H. G. Rammensee. 1993. Allele-specific peptide ligand motifs of HLA-C molecules. Proc. Natl. Acad. Sci. USA 90:12000.
40. Sodeoka, M., C. J. Larson, L. Chen, K. P. LeClair, and G. L. Verdine. 1993. A multifunctional plasmid for protein expression by ECPCR: overproduction of the p50 subunit of NF-KB. Bioorg. & Med. Chem. Lett. 3:1089.
41. Studier, F. W., A. H. Rosenberg, J. J. Dunn, and J. W. Dubendorff. 1990. Use of T7 RNA polymerase to direct expression of cloned genes. Methods Enzymol. 185:60.
42. Nagai, K., and H. C. Thogersen. 1987. Synthesis and sequence-specific proteolysis of hybrid proteins produced in Escherichia coli. Methods Enzymol. 115:61.
43. Garboczi, D. N., U. Utz, P. Ghosh, A. Seth, J. Kim, E. A. E. van Tienhoven, W. E. Biddison, and D. C. Wiley. 1996. Assembly, specific binding, and crystallization of a human TCR-αβ with an antigenic TAX peptide from human T lymphotropic virus type I and the class I MHC molecule HLA-A2. J. Immunol. 157:5403.
44. Rojo, S., N. Wagtmann, and E. O. Long. 1997. Binding of a soluble p70 killer cell inhibitory receptor to HLA-B*5101: requirement for all three p70 immunoglobulin domains. Eur. J. Immunol. 27:568.
45. Sidney, J., M. F. del Guercio, S. Southwood, V. H. Engelhard, E. Appella, H.-G. Rammensee, K. Falk, O. Rötzschke, M. Takiguchi, R. T. Kubo, H. M. Grey, and A. Sette. 1995. Several HLA alleles share overlapping peptide specificities. J. Immunol. 154:247.
46. Kim, J., E. Van Tienhoven, D. N. Garboczi, U. Utz, and D. C. Wiley. 1996. Specific binding of a soluble recombinant β-chain T-cell antigen receptor to toxic shock syndrome toxin-1, a superantigcn. Molecules and Cells. 6:590.
47. Seth, A., L. J. Stern, T. H. Ottenhoff, I. Engel, M. J. Owen, J. R. Lamb, R. D. Klausner, and D. C. Wiley. 1994. Binary and ternary complexes between T-cell receptor, class II MHC and superantigen in vitro. Nature 369:324.
48. Rajagopalan, S., C. C. Winter, N. Wagtmann, and E. O. Long. 1995. The Ig-related killer cell inhibitory receptor binds zinc and requires zinc for recognition of HLA-C on target cells. J. Immunol. 155:4143.
49. Correa, I., and D. H. Raulet. 1995. Binding of diverse peptides to MHC class I molecules inhibits target cell lysis by activated natural killer cells. Immunity 2:61.
50. Mandelboim, O., H. T. Reyburn, M. Vales-Gomez, L. Pazmany, M. Colonna, G. Borsellino, and J. L. Strominger. 1996. Protection from lysis by natural killer cells of group 1 and group 2 specificity is mediated by residue 80 in human histocompatibility leukocyte antigen C alleles and also occurs with empty major histocompatibility complex molecules. J. Exp. Med. 184:913.
51. Chadwick, B. S., and R. G. Miller. 1992. Hybrid resistance in vitro: possible role of both class I and self peptides in determining the level of target cell sensitivity. J. Immunol. 148:2307.
52. Storkus, W. J., R. D. Salter, P. Cresswell, and J. R. Dawson. 1992. Peptide-induced modulation of target cell sensitivity to natural killing. J. Immunol. 149:1185.
53. Malnati, M. S., M. Peruzzi, K. C. Parker, W. E. Biddison, E. Ciccone, A. Moretta, and E. O. Long. 1995. Peptide specificity in the recognition of MHC class I by natural killer cell clones. Science 267:1016.
54. Peruzzi, M., K. C. Parker, E. O. Long, and M. S. Malnati. 1996. Peptide sequence requirements for the recognition of HLA-B2705 by specific natural killer cells. J. Immunol 157:3350.
55. Rajagopalan. S., and E. O. Long. 1997. The direct binding of a p58 killer cell inhibitory receptor to human histocompatibility leukocyte antigen (HLA)-Cw4 exhibits peptide selectivity. J. Exp. Med. 185:1523.
56. Garboczi, D. N., P. Ghosh, U. Utz, Q. R. Fan, W. E. Biddison, and D. C. Wiley. 1996. Structure of the complex between human T-cell receptor, viral peptide and HLA-A2. Nature 384:134.
57. Garcia, K. C., M. Dengano, R. L. Stanfield, A. Brummark, M. R. Jackson, P. A. Peterson, L. Teyton, and I. A, Wilson. 1996. An αβ T cell receptor structure at 2.5A and its orientation in the TCR-MHC complex. Science 274:209.
58. Storkus, W. J., R. D. Salter, and J. Alexander. 1991. Class I-induced NK resistance in human B cell targets: identification of non-permissive residues in HLA-A2. Proc. Natl. Acad. Sci. USA 88:5989.
59. Biassoni, R., M. Falco, A. Cambiaggi, P. Costa, S. Verdiani, D. Pende, R. Conte, C. Di Donato, P. Parham, and L. Moretta. 1995. Amino acid substitutions can influence the NK-mediated recognition of HLA-C molecules: role of serine 77 and lysine 80 in the target cell protection from lysis mediated by "group 2" or "group 1" NK clones. J. Exp. Med. 182:605.
60. Burmeister, W. P., A. H. Huber, and P. J. Bjorkman. 1994. Crystal structure of the complex of rat neonatal Fc receptor with Fc. Nature 372:379.
61. Kim, J., R. G. Urban, J. L. Strominger, and D. C. Wiley. 1994. Toxic shock syndrome toxin-1 complexed with a class II major histocompatibility molecule HLA-DR1. Science 266:1870.
62. Von Bonin, A., S. Ehrlich, G. Malcherek, and B. Fleischer. 1995. Major histocompatibility complex class II-associated peptides determine the binding of the superantigen toxic shock syndrome toxin-1. Eur. J. Immunol. 25:2894.